The American Academy of Pediatrics (AAP) has released its updated recommendations for influenza vaccination and antiviral treatment for children for the 2026–2027 flu season. The guidance, issued by the AAP Committee on Infectious Diseases, reaffirms that all children aged 6 months and older should receive the annual influenza vaccine.
According to the AAP, the vaccine remains the most effective way to prevent severe illness, hospitalization, and death from influenza. The recommendations emphasize that vaccination should be offered as soon as the vaccine becomes available, ideally by the end of October. For children aged 6 months through 8 years who are receiving the vaccine for the first time, two doses are recommended, spaced at least four weeks apart.
The AAP also updated guidance on the use of antiviral medications, such as oseltamivir, for the treatment and prevention of influenza in children. These medications are recommended for children with confirmed or suspected influenza who are at high risk of complications, including those with chronic medical conditions, and for children who are hospitalized or have severe illness.
Parents and caregivers are encouraged to consult their pediatrician about the flu vaccine and any questions regarding influenza prevention and treatment. The AAP's full policy statement is published in the journal Pediatrics.
